Significant variation exists in the outcomes used in cancer cachexia trials, including
measures of body composition, which are often selected as primary or secondary endpoints …

Cancer cachexia is a complex metabolic disorder marked by unintentional body weight loss
or 'wasting'of body mass, driven by multiple aetiological factors operating at various levels. It …

Exercise training reduces the incidence of several cancers, but the mechanisms underlying
these effects are not fully understood. Exercise training can affect the spleen function, which …

Body composition assessment (ie, the measurement of muscle and adiposity) impacts
several cancer-related outcomes including treatment-related toxicities, treatment responses …

Simple Summary Cachexia occurs in up to 80% of patients with cancer. Although cancer-
associated cachexia dramatically decreases overall survival and quality of life, it is often …

Simple Summary Cancer is a major burden of disease worldwide, with cancer cachexia
being a poor prognosis factor which leads to a decreased quality of life and overall survival …

Objective Visceral fat mass (VFM) is a risk factor for cardiovascular diseases, type 2 diabetes
mellitus, and malignancy; however, normative data are limited. The aim of this study was to …

Background Cancer‐associated cachexia (CAC) is a metabolic syndrome contributing to
therapy resistance and mortality in lung cancer patients (LCP). CAC is typically defined …

Recently, the study of the relationship between lipid metabolism and cancer has evolved.
The characteristics of intratumoral and peritumoral fat are distinct and changeable during …

Introduction Cancer-associated cachexia (CC) is a progressive syndrome characterized by
unintentional weight loss, muscle atrophy, fatigue, and poor outcomes that affects most …